Inhibrx Inc (INBX)
34.46
-0.15
(-0.43%)
USD |
NASDAQ |
Apr 18, 16:00
34.50
+0.04
(+0.10%)
After-Hours: 20:00
Inhibrx 1 Year Total Returns (Daily): 69.67% for April 18, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 18, 2024 | 69.67% |
April 17, 2024 | 73.74% |
April 16, 2024 | 89.64% |
April 15, 2024 | 90.36% |
April 12, 2024 | 105.8% |
April 11, 2024 | 102.8% |
April 10, 2024 | 106.2% |
April 09, 2024 | 103.7% |
April 08, 2024 | 102.3% |
April 05, 2024 | 101.4% |
April 04, 2024 | 94.23% |
April 03, 2024 | 86.89% |
April 02, 2024 | 84.68% |
April 01, 2024 | 84.79% |
March 28, 2024 | 83.61% |
March 27, 2024 | 73.07% |
March 26, 2024 | 81.71% |
March 25, 2024 | 81.04% |
March 22, 2024 | 69.95% |
March 21, 2024 | 60.86% |
March 20, 2024 | 62.26% |
March 19, 2024 | 67.42% |
March 18, 2024 | 67.18% |
March 15, 2024 | 55.14% |
March 14, 2024 | 48.39% |
Date | Value |
---|---|
March 13, 2024 | 54.98% |
March 12, 2024 | 64.29% |
March 11, 2024 | 63.92% |
March 08, 2024 | 52.27% |
March 07, 2024 | 49.23% |
March 06, 2024 | 50.74% |
March 05, 2024 | 47.21% |
March 04, 2024 | 47.46% |
March 01, 2024 | 51.94% |
February 29, 2024 | 52.24% |
February 28, 2024 | 53.78% |
February 27, 2024 | 66.78% |
February 26, 2024 | 67.20% |
February 23, 2024 | 56.37% |
February 22, 2024 | 58.13% |
February 21, 2024 | 66.22% |
February 20, 2024 | 58.91% |
February 16, 2024 | 64.47% |
February 15, 2024 | 62.77% |
February 14, 2024 | 61.11% |
February 13, 2024 | 60.42% |
February 12, 2024 | 63.94% |
February 09, 2024 | 62.26% |
February 08, 2024 | 57.75% |
February 07, 2024 | 51.67% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-65.47%
Minimum
Jun 15 2022
215.6%
Maximum
Jun 14 2023
13.88%
Average
-1.43%
Median
1 Year Total Returns (Daily) Benchmarks
Johnson & Johnson | -6.71% |
Gilead Sciences Inc | -17.92% |
Outlook Therapeutics Inc | -61.97% |
Axonics Inc | 16.85% |
NovaBay Pharmaceuticals Inc | -95.06% |